Starton Therapeutics

Transforming therapies with proprietary continuous delivery technology, so people with cancer live better, for longer.

[Starton Therapeutics @startontx]

💡 More IP news! Read about it here: https://t.co/fetBhyQQs9

[Starton Therapeutics @startontx]

News alert 📢 read more here: https://t.co/BzCokPDuQ3

[Starton Therapeutics @startontx]

Starton Therapeutics Announces Dosing of First Patient in Phase 2a Study Evaluating STAR-LLD for the Treatment of Multiple Myeloma. Read more here: https://t.co/hwJbmsLErR

[Starton Therapeutics @startontx]

It was great presenting at #BiotechShowcase this week! Thank you to the organizers and everyone who joined the discussion. We look forward to continuing the engaging conversations. #JPM26

[Starton Therapeutics @startontx]

Starton Therapeutics is presenting in San Francisco this January 12–14, 2026. https://t.co/4bkWedPfJI

Let’s connect at #BiotechShowcase!

Secure your spot and set up one-to-one meetings here: https://t.co/sBXYcbrlGd

[Starton Therapeutics @startontx]

We are pleased to announce that Dr. Jamie Oliver, our Chief Medical Officer, will present in an upcoming Labroots webinar sponsored by Primetech Corporation discussing The Journey From Idea to Impact on October 29, to learn more please visit: https://t.co/w0ogD8kCNv

[Starton Therapeutics @startontx]

Starton Therapeutics Announces Vice President of Research and Development/Manufacturing. Read more here: https://t.co/mhTtMGS8aB

[Starton Therapeutics @startontx]

Pedro Lichtinger, Starton's Chairman & CEO, will be participating in a panel on Driving Productivity in R&D at the Boston CEO Conference. To learn more and join the conversation please visit: https://t.co/kbh5Wbg7nk #longwoodhealthcareleaders #BostonCEO

[Starton Therapeutics @startontx]

For patients & families, #BloodCancerAwareness doesn’t end in September. It’s every appointment, every treatment, every worry—and every victory. We’re committed to better treatments, because for them, it’s every day.

[Starton Therapeutics @startontx]

Today is World Cancer Research Day. Research is the key to better treatments, brighter futures, and saving lives. Today we honor those who work tirelessly to advance new treatment options in the pursuit of helping patients. #WorldCancerResearchDay #ResearchSavesLives

[Starton Therapeutics @startontx]

In the U.S., an estimated 176,400 people are living with myeloma, the second most common blood cancer. Advances in the treatments have improved remission rates, quality of life and survival. However, more work needs to be done.

[Starton Therapeutics @startontx]

Leukemia is a broad term for cancer of the blood cells, classified by the cell type and growth speed. Leukemia occurs most often in adults older than 55, but it is also the most common cancer in children younger than 15. #BeLeukemiaAware

[Starton Therapeutics @startontx]

Starton Therapeutics further expands its intellectual property portfolio surrounding lead candidate, STAR-LLD. Read more here: https://t.co/0oFiGpvjif

[Starton Therapeutics @startontx]

There are approximately 825,651 people living with, or in remission from, lymphoma in the US. Increasing awareness of lymphoma will help people better recognize signs and symptoms, leading to earlier diagnosis and more timely treatment. #WorldLymphomaAwarenessDay

[Starton Therapeutics @startontx]

An estimated combined total of 192,000 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2025. These cases account for approximately 10% of the new cancer diagnoses.

[Starton Therapeutics @startontx]

There are over 100 types of blood cancer, including some rare forms you may have never heard of. Blood cancer affects the blood cells, bone marrow, lymph nodes and other parts of the lymphatic system requiring innovative and specialized treatments. #BloodCancerAwarenessMonth

[Starton Therapeutics @startontx]

Behind every blood cancer diagnosis is a family that refuses to give up hope. At Starton, we refuse to give up hope too. This Blood Cancer Awareness Month, we’re shining a light on the fight against blood cancer. ❤️ #BloodCancerAwarenessMonth #kNOwmyeloma #letstalklymphoma

[Starton Therapeutics @startontx]

“We are excited to enter into this agreement with @Bend_Bioscience for the development of an oral sustained release formulation of STAR-LLD” said Pedro Lichtinger, Starton Therapeutics Chairman and CEO. Read more here: https://t.co/knb7OuF9Tq

[Starton Therapeutics @startontx]

We’re pleased to share that our Phase 2a clinical trial evaluating STAR-LLD in patients with multiple myeloma is now open for enrollment. This is an important step forward in our mission to develop innovative therapies for patients. Read more here: https://t.co/RKbTSNKCq5

[Starton Therapeutics @startontx]

Sunday is #NationalCancerSurvivorsDay, we honor the strength, courage, and resilience of those who face cancer. At Starton, we're advancing innovative solutions to potentially improve outcomes and quality of life. Here's to life, hope, and perseverance. #CancerAwareness